1st Quarter - Report — STRYKER CORPORATION for STRYKER CORPORATION (2013)

Firm

STRYKER CORPORATION

Client

STRYKER CORPORATION

Income

—

Expenses

$70,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Taxation/Internal Revenue Code TAX

S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff
ERIC RUGO	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 523 (113th), S. 232 (113th)

Medicare/Medicaid MMM

Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff
ERIC RUGO	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. 933, Consolidated and Further Continuing Appropriations Act of 2013, particularly appropriations for the FDA Center for Devices and Radiological Health

Lobbyist	Covered position, as disclosed
PAGE KRANBUHL	Senate HELP Subcommittee staff

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 933 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.